Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
22,163,711
-
Number of holders
-
152
-
Total 13F shares, excl. options
-
94,361,848
-
Shares change
-
-784,032
-
Total reported value, excl. options
-
$1,022,948,988
-
Value change
-
-$6,881,994
-
Put/Call ratio
-
159%
-
Number of buys
-
73
-
Number of sells
-
-75
-
Price
-
$10.84
Significant Holders of Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) as of Q4 2020
189 filings reported holding ADVM - Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share as of Q4 2020.
Adverum Biotechnologies, Inc. - Common Stock, par value $0.0001 per share (ADVM) has 152 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 94,361,848 shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (9,502,383 shares), Avoro Capital Advisors LLC (8,000,000 shares), RTW INVESTMENTS, LP (7,227,364 shares), BlackRock Inc. (7,042,768 shares), ORBIMED ADVISORS LLC (5,501,144 shares), Sonic Fund II, L.P. (5,101,787 shares), Versant Venture Management, LLC (5,003,892 shares), VANGUARD GROUP INC (4,478,951 shares), STATE STREET CORP (4,264,590 shares), and Casdin Capital, LLC (3,650,000 shares).
This table shows the top 152 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.